Radiotherapy enhancement with gold nanoparticles
Усиление радиотерапии с помощью золотых наночастиц
2008-07-11
SCID: 54.1/wtrjb7d6
Discuss with AI
EMT-6 mouse mammary tumorsX-ray absorptiondose enhancementgold nanoparticlesradiotherapy enhancement
Figures from the paper
Abstract (AI)
Gold is an excellent absorber of X-rays. If tumours could be loaded with gold, this would lead to a higher dose to the cancerous tissue compared with the dose received by normal tissue during a radiotherapy treatment. Calculations indicate that this dose enhancement can be significant, even 200% or greater. In this paper, the physical and biological parameters affecting this enhancement are discussed. Gold nanoparticles have shown therapeutic efficacy in animal trials and these results are reviewed. Some 86% long-term (>1 year) cures of EMT-6 mouse mammary subcutaneous tumours was achieved with an intravenous injection of gold nanoparticles before irradiation with 250-kVp photons, whereas only 20% were cured with radiation alone. The clinical potential of this approach is also discussed.
Key Findings
1
Animal studies demonstrated therapeutic efficacy of gold nanoparticles as radiotherapy enhancers.
2
Gold nanoparticles can enhance tumour radiation dose because gold strongly absorbs X-rays, with calculations predicting dose increases of 200% or more.
3
Intravenous gold nanoparticles before 250-kVp irradiation produced 86% long-term cures of EMT-6 mouse mammary tumours, compared with 20% for radiation alone.
4
The approach shows clinical potential, although its effectiveness depends on translating nanoparticle-mediated dose enhancement to clinical treatment settings.
5
The magnitude of radiotherapy enhancement depends on physical and biological parameters governing nanoparticle distribution and radiation interactions.
Research Object
Gold nanoparticle-loaded tumours during radiotherapy
Research Subject
Physical and biological factors governing radiotherapy dose enhancement and therapeutic efficacy
Publication Details
Publication Date
2008-07-11
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest